|
| | Issue Date | Title | Contributor(s) | Type | Cat. |
| 1 | 2026 | Efficacy of olaparib in advanced cancers with somatic or germline mutations in BAP1, BARD1, BRIP1 and PALB2 | Joris, S.; Denys, H.; Collignon, J.; Rasschaert, M.; de Roodenbeke, D. T.; Duhoux, F. P.; Canon, J. L.; Tejpar, S.; MEBIS, Jeroen; Decoster, L.; Aftimos, P.; De Greve, J. | Journal Contribution | A1 |
| 2 | 2026 | Evaluating the efficacy of photobiomodulation therapy in the management of chemotherapy-induced peripheral neuropathy: a pilot trial (NEUROLIGHT trial) | CLAES, Marithe; LODEWIJCKX, Joy; ROBIJNS, Jolien; Hermans, Sylvia; Peeters, Pascal; MEBIS, Jeroen | Journal Contribution | A1 |
| 3 | 2026 | Targeting Dermatologic Side Effects of Immunotherapy Using Novel Skin Care Products | CLAES, Marithe; LODEWIJCKX, Joy; ROBIJNS, Jolien; Tuts, Laura; LENAERTS, Mellisa; Vandaele, Eline; Wessels, Tim; REQUILÉ, Annelies; Luyten, Daisy; Verheezen, Yolanda; Joosens, Eric; MEBIS, Jeroen | Journal Contribution | A1 |
| 4 | 2026 | A phase IV prospective study of efficacy and safety of ribociclib and letrozole as first-line therapy in older women (≥70 years) with hormone receptor-positive HER2-negative advanced breast cancer: the RibOB study | Van Houdt, M.; Kenis, C.; De Nys, L.; Hatse, S.; Neven, P.; Laenen, A.; MEBIS, Jeroen; De Azambuja, E.; Ponde, N. F.; Decoster, L.; Quaghebeur, C.; Cornelis, F.; Verhoeven, D. M. E. C.; Barbeaux, A.; Wildiers, H.; VERSCHAEVE, G. | Journal Contribution | A1 |
| 5 | 2026 | impact of second primary cancers on radiotherapy of newly diagnosed head and neck tumors | Bortels, Mirte; Bollen , Heleen; Govers, Mieke; van de Velde, Anne Sophie; Cornillie, Jasmien; Mennens, Ferdinand; MEBIS, Jeroen; Jeurisse, Daisy; REQUILÉ, Annelies; MAES, Annelies | Journal Contribution | M |
| 6 | 2026 | Geneo study: Comprehensive genomic profiling versus limited local reimbursed NGS panels within the belgian Precision initiative | Toungouz, Gordana Raiceivc; Hebrant, Aline; Nannini, Simon; Van Marcke, Cedric; Maetens, Julie; Decoster, Lore; Rottey, Sylvie; Demey, Wim; Collignon, Joelle; Rutten, Annemie; Vanden Bempt, Isabelle; Vermeij, Joanna; Tejpar, Sabine; Canon, Jean-Luc.; Van den Mooter, Tom; Lybaert, Willem; Van der Meulen, Joni; D'Haene, Nicky; MEBIS, Jeroen; Prenen, Hans; Van den Bulcke, Marc; De Greve, Jacques; MAES, Brigitte; Punie, Kevin; Aftimos, Philippe | Journal Contribution | A1 |
| 7 | 2025 | Hypercalcemia as an Immune-Related Adverse Event in a Patient Receiving Nivolumab and Ipilimumab for Metastatic Melanoma: A Case Report | Plessers, Sam; MEBIS, Jeroen; De Moor, Nina; Wessels, Tim; Luyten, Daisy; REQUILÉ, Annelies; Mayordomo, Jose I. | Journal Contribution | A1 |
| 8 | 2025 | Photobiomodulation therapy in the prevention of chemotherapy-induced alopecia in breast cancer patients: a randomized controlled trial | CLAES, Marithe; ROBIJNS, Jolien; Lambrichts , Laura; Van Duffel, Sofie; Bulens, Philippe; MEBIS, Jeroen | Journal Contribution | A1 |
| 9 | 2025 | Targeting Fear of Cancer Recurrence with Internet-Based Emotional Freedom Techniques (iEFT) and Mindfulness Meditation Intervention (iMMI) (BGOG-gyn1b/REMOTE) | Tack, Laura; Mertens , Lore; Vandeweyer, Marte; Florin, Fien; Pauwels, Emma; Baert, Thais; Boterberg, Tom; Fontaine, Christel; Geldhof, Kurt; Lamot, Caroline; Langenaeken, Christine; Teuwen, Laure-Anne; MEBIS, Jeroen; VANDENBORRE, Katherine; van den Bulck, Heidi; Van Ryckeghem, Florence; Najlah, Mohammad; Schofield, Patricia; Debruyne, Philip R. | Journal Contribution | A1 |
| 10 | 2025 | A nationwide comprehensive genomic profiling and molecular tumor board platform for patients with advanced cancer | VOLDERS, Pieter-Jan; Aftimos, Philippe; Dedeurwaerdere, Franceska; Martens, Geert; Canon, Jean-Luc; Beniuga, Gabriela; Van Huysse, Jacques; FROYEN, Guy; De Pauw, Rebecca; Prenen, Hans; Lambin, Suzan; Decoster, Lore; Vaeyens, Freya; Rottey, Sylvie; Van Dam, Pieter-Jan; Decoster, Lynn; Rutten, Annemie; Schreuer, Max; Loontiens, Siebe; van der Meulen, Joni; MEBIS, Jeroen; CUPPENS, Kristof; Tejpar, Sabine; Vanden Bempt, Isabelle; De Greve, Jacques; Schroeder, David; van Marcke, Cedric; van den Bulcke, Marc; de Azambuja, Evandro; Punie, Kevin; MAES, Brigitte | Journal Contribution | A1 |
| 11 | 2024 | Cancer therapy-related vaginal toxicity: its prevalence and assessment methods-a systematic review | CLAES, Marithe; Tuts, L.; ROBIJNS, Jolien; Mulders, K.; van de Werf, E.; BULENS, Paul; MEBIS, Jeroen | Journal Contribution | A1 |
| 12 | 2024 | Pyridoxamine Limits Cardiac Dysfunction in a Rat Model of Doxorubicin-Induced Cardiotoxicity | HAESEN, Sibren; DE LAAT, Iris; JAGER, Manon Marie; Brillouet, Aline; VASTMANS, Lotte; VERGHOTE, Eline; DELAET, Anouk; D'HAESE, Sarah; HAMAD, Ibrahim; KLEINEWIETFELD, Markus; MEBIS, Jeroen; MULLENS, Wilfried; LAMBRICHTS, Ivo; WOLFS, Esther; DELUYKER, Dorien; BITO, Virginie | Journal Contribution | A1 |
| 13 | 2024 | Evaluating pain management practices for cancer patients among health professionals in cancer and supportive/palliative care units: a Belgian survey | Fontaine, C; Libert, I; Echterbille, MA; Bonhomme, V; Botterman, J; Bourgonjon, B; Brouillard, V; Courtin, Y; De Buck, J; Debruyne, PR; Delaat, M; Delperdange, JM; Duck, L; Everaert, Els; Lamot, C; Holbrechts, S; Lossignol, D; Krekelbergh, F; Langenaeken, C; Lapeire, L; Naert, E; Lauwers, Koen; Matic, M; MEBIS, Jeroen; Miedema, G; Pieterbourg, M; Plehiers, B; Punie, K; Roblain, F; Schrijvers, D; Serre, CH; Vandenborre, K; Broecke, AV; van den Bulk, H; Vanopdenbosch, L; Van Ryckeghem, F; Verheezen, J; Verschaeve , V; Voordeckers, M; Klastersky, J | Journal Contribution | A1 |
| 14 | 2023 | Efficacy of olaparib in advanced cancers with germline or somatic mutations in BRCA1, BRCA2, CHEK2 and ATM, a Belgian Precision tumor-agnostic phase II study | Joris, S; Denys, H; Collignon, J; Rasschaert, M; de Roodenbeke, DT; Duhoux, FP; Canon, JL; Tejpar, S; MEBIS, Jeroen; Decoster, L; Aftimos, P; De Grève, J | Journal Contribution | A1 |
| 75 | 2023 | Steroid-dependent pericarditis following anti-PD1 immunotherapy in a metastatic melanoma patient: a case report | Verhaert, Marthe; MEBIS, Jeroen; Aspeslagh, Sandrine; von Kemp, Berlinde; Rossi, Valentina; Komorovsky, Roman; Gambaro, Alessia; Kovacs, Boldizsar; Peverelli, Marta; Jathanna, Nikesh | Journal Contribution | A1 |
| 76 | 2023 | The use of photobiomodulation therapy for the management of chemotherapy-induced alopecia: a randomized, controlled trial (HAIRLASER trial) | LODEWIJCKX, Joy; ROBIJNS, Jolien; CLAES, Marithe; Pierson, Maud; Lenaerts, Melissa; MEBIS, Jeroen | Journal Contribution | A1 |
| 77 | 2023 | Afatinib for EGFR, HER2 or HER3 mutated solid tumors: A phase II Belgian precision study | Decoster, L.; Aftimos, P. G.; Rottey, S.; Prenen, H.; Collignon, J. J.; MEBIS, Jeroen; Canon, J-L.; Fastenaekels, V.; Cappoen, N.; Joris, S. R.; De Greve, J. | Journal Contribution | M |
| 78 | 2023 | Evaluation of a novel skin care product for the management of chemotherapy-related dermatologic toxicities: A quasi-experimental study | ROBIJNS, Jolien; LODEWIJCKX, Joy; CLAES, Marithe; Tuts, Laura; Lenaerts, Melissa; Wessels, Tim; Requilé, Annelies; Luyten, Daisy; Verheezen, Jolanda; Joosens, Eric; MEBIS, Jeroen | Journal Contribution | A1 |
| 79 | 2023 | Photobiomodulation in the management of chemotherapy-induced peripheral neuropathy: a randomized, controlled trial | CLAES, Marithe; LODEWIJCKX, Joy; Hermans, S.; Peeters, P.; MEBIS, Jeroen; ROBIJNS, Jolien | Journal Contribution | M |
| 80 | 2023 | Efficacy of olaparib in advanced cancers with germline or somatic tumor mutations in BRCA1, BRCA2, CHEK2 and ATM: A Belgian precision tumor-agnostic phase II study | Joris, S. R.; Denys, H.; Collignon, J. J.; Rasschaert, M.; de Roodenbeke, D. T'Kint; Duhoux, F. P.; Canon, J-L.; Tejpar, S.; MEBIS, Jeroen; Decoster, L.; Aftimos, P. G.; De Greve, J. | Journal Contribution | M |